BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 3967174)

  • 1. Long-term results and prognostic factors in patients with differentiated thyroid carcinoma.
    Tubiana M; Schlumberger M; Rougier P; Laplanche A; Benhamou E; Gardet P; Caillou B; Travagli JP; Parmentier C
    Cancer; 1985 Feb; 55(4):794-804. PubMed ID: 3967174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
    Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
    Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term results in elderly patients with differentiated thyroid carcinoma.
    Vini L; Hyer SL; Marshall J; A'Hern R; Harmer C
    Cancer; 2003 Jun; 97(11):2736-42. PubMed ID: 12767085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrence factors and prevention of complications of pediatric differentiated thyroid cancer.
    Wang C; Chen X; Wei X; Chen F; Wang Y; Shen Z
    Asian J Surg; 2017 Jan; 40(1):55-60. PubMed ID: 27697309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors determining long-term survival in well-differentiated thyroid cancer: an analysis of four hundred eighty-four patients undergoing therapy and aftercare at the same institution.
    Eichhorn W; Tabler H; Lippold R; Lochmann M; Schreckenberger M; Bartenstein P
    Thyroid; 2003 Oct; 13(10):949-58. PubMed ID: 14611704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
    Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifactorial analysis of survival and recurrences in differentiated thyroid cancer. Comparative evaluation of usefulness of AGES, MACIS, and risk group scores in Mexican population.
    Rodríguez-Cuevas S; Labastida-Almendaro S; Cortés-Arroyo H; López-Garza J; Barroso-Bravo S
    J Exp Clin Cancer Res; 2002 Mar; 21(1):79-86. PubMed ID: 12071534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes of distant metastasis from differentiated thyroid carcinoma.
    Huang IC; Chou FF; Liu RT; Tung SC; Chen JF; Kuo MC; Hsieh CJ; Wang PW
    Clin Endocrinol (Oxf); 2012 Mar; 76(3):439-47. PubMed ID: 21950769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of lymph node metastasis in differentiated carcinoma of the thyroid: a matched-pair analysis.
    Hughes CJ; Shaha AR; Shah JP; Loree TR
    Head Neck; 1996; 18(2):127-32. PubMed ID: 8647677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
    Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
    Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonanaplastic follicular cell-derived thyroid carcinoma: mitosis and necrosis in long-term follow-up.
    Skansing DB; Londero SC; Asschenfeldt P; Larsen SR; Godballe C
    Eur Arch Otorhinolaryngol; 2017 Jun; 274(6):2541-2548. PubMed ID: 28293786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of patients with insular carcinoma of the thyroid: the insular histotype is an independent predictor of poor prognosis.
    Pellegriti G; Giuffrida D; Scollo C; Vigneri R; Regalbuto C; Squatrito S; Belfiore A
    Cancer; 2002 Nov; 95(10):2076-85. PubMed ID: 12412160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Draft of the best medical treatment in patients with low-risk thyroid cancer].
    Vlček P; Nováková D; Vejvalka J; Zimák J; Křenek M; Vošmiková K; Smutný S; Bavor P; Astl J; Lukáš J
    Vnitr Lek; 2015 Sep; 61(9):769-77. PubMed ID: 26465275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic factors of differentiated thyroid cancers. 536 cases].
    Tourniaire J; Bernard-Auger MH; Adeleine P; Milan JJ; Fleury-Goyon MC; Dutrieux-Berger N
    Ann Endocrinol (Paris); 1989; 50(3):219-24. PubMed ID: 2683975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Poorly differentiated thyroid follicular carcinoma - a clinical analysis of 30 cases].
    Liu WS; Qi YF; Tang PZ
    Ai Zheng; 2004 Sep; 23(9):1081-4. PubMed ID: 15363207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic nomograms to predict oncological outcome of thyroid cancers.
    Pathak KA; Mazurat A; Lambert P; Klonisch T; Nason RW
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4768-75. PubMed ID: 24152685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifactorial study of prognostic factors in differentiated thyroid carcinoma.
    Palestini N; Cappello N; Cottino F; Durando R; Vecchiato D; Rendine S; Abeatici S
    Ital J Surg Sci; 1989; 19(2):137-44. PubMed ID: 2753685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic factors of papillary carcinomas of the thyroid gland--retrospective multivariate analysis of 227 patients with median follow-up 130 months].
    Kure Y
    Nihon Geka Gakkai Zasshi; 1992 Nov; 93(11):1420-6. PubMed ID: 1448049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma.
    Zaydfudim V; Feurer ID; Griffin MR; Phay JE
    Surgery; 2008 Dec; 144(6):1070-7; discussion 1077-8. PubMed ID: 19041020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic indices for tumor relapse and tumor mortality in follicular thyroid carcinoma.
    Mueller-Gaertner HW; Brzac HT; Rehpenning W
    Cancer; 1991 Apr; 67(7):1903-11. PubMed ID: 2004304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.